-- 
India Equity Movers: Bharti Airtel, Ranbaxy, Reliance Industries

-- B y   A m e y a   K a r v e
-- 
2011-05-05T12:46:46Z

-- http://www.bloomberg.com/news/2011-05-05/india-equity-movers-bharti-piramal-life-ranbaxy-reliance.html
The following companies had unusual
price changes in  India  trading. Stock symbols are in parentheses
and share prices are as of the 3:30 p.m. close in Mumbai.  The Bombay Stock Exchange Sensitive Index, or Sensex,
dropped 258.78, or 1.4 percent, to 18,210.58, the lowest in more
than a month. The BSE 200 Index slid 1.4 percent to 2,249.40.
The gauges fell for the ninth straight day.  Bharti Airtel Ltd. (BHARTI)   retreated 3.2 percent to
357.9 rupees, its biggest fall in more than three months.
India’s largest mobile-phone operator said fourth-quarter profit
fell 31 percent after higher costs for network and advertising
expenses eroded margins.  Canara Bank (CBK)   fell 2.6 percent to 558.65 rupees, its
lowest close in more than two months. The lender posted a net
income of 8.99 billion rupees in the fourth quarter, missing
analysts’ estimates of 11.2 billion rupees.  Jyothy Laboratories Ltd. (JYL)   soared 8.1 percent to
223.25 rupees, the steepest advance since June 18. A global
private equity fund is likely to buy at least 26 percent stake
in the household-products maker for about $150 million, the
Economic Times reported today, citing people it didn’t identify.
The company said the report was “speculative” in an exchange
filing.  Kotak Mahindra Bank Ltd. (KMB)   climbed 2.2 percent to
422 rupees, its steepest advance in more than two weeks. The
lender, controlled by Indian billionaire Uday Kotak, posted a 17
percent increase in fourth-quarter net income, according to an
exchange filing.  NTPC Ltd. (NTPC IN) decreased 2.6 percent to 173.95 rupees,
its lowest in more than a month. India will cancel five coal
mining leases alloted to the country’s largest power producer
for “slow or non-implementation” of the projects, according to
an e-mailed statement from the coal ministry today.  Piramal Life Sciences Ltd. (PLSL)  , a drug-research
company, surged 9.9 percent to 104.1 rupees, its steepest climb
in seven weeks.  Piramal Healthcare Ltd. (PIHC)  , which owns
17.88 percent of the Piramal Life, will consider a proposal to
merge a unit of the company with itself, according to an
exchange filing. Piramal Healthcare fell 0.5 percent to 458.5
rupees.  Ranbaxy Laboratories Ltd. (RBXY)   plunged 6 percent to
426.35 rupees, its lowest close in almost 11 months. U.S.
federal prosecutors are negotiating a settlement with India’s
largest drugmaker by revenue that could result in fines and
payments exceeding $1 billion, Fortune magazine reported, citing
people with knowledge of the talks. The company declined to
comment, according to an e-mailed statement.  Reliance Industries Ltd. (RIL)   rose 1.1 percent to
949.95 rupees, its highest advance in a week. India’s biggest
listed firm by market value plans to invest as much as $12
billion in the chemicals business, the Economic Times reported,
citing an interview with Chairman  Mukesh Ambani . It will also
increase output of natural gas from the KG-D6 block after
analyzing data for a few more quarters with the help of BP Plc,
the newspaper said. Manoj Warrier, a Reliance Industries
spokesman, declined to comment on the report.  Sundaram Clayton Ltd. (SDC IN) advanced 2.3 percent to
153.6 rupees. The auto-part maker’s net income for the three
months ended March 31 more than trebled to 157.1 million rupees,
according to an exchange filing.  Thermax Ltd. (TMX)   slid 3.5 percent to 591.75 rupees,
its lowest close in more than a month. The power equipment
maker, which fell for the fifth day, was cut to “sell” from
“hold” at Citigroup Inc., which cited a “muted” outlook for
order inflows. The brokerage reduced its share-price estimate to
542 rupees from 698 rupees, analysts led by Deepal Delivala
wrote in a report.  To contact the reporter on this story:
Ameya Karve in Mumbai at 
 akarve@bloomberg.net .  To contact the editor responsible for this story:
Darren Boey at 
 dboey@bloomberg.net . 